Bausch Health Cos Price to Book Ratio 2012-2026 | BHC
Historical price to book ratio values for Bausch Health Cos (BHC) over the last 10 years. The current price to book ratio for Bausch Health Cos as of September 16, 2026 is 0.00.
| Bausch Health Cos Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-17 | 5.65 | 0.00 | |
| 2026-06-30 | 4.93 | $-2.15 | -2.30 |
| 2026-03-31 | 5.40 | $-2.90 | -1.86 |
| 2025-12-31 | 6.95 | $1.02 | 6.83 |
| 2025-09-30 | 6.45 | $0.96 | 6.71 |
| 2025-06-30 | 6.66 | $0.40 | 16.75 |
| 2025-03-31 | 6.47 | $-0.65 | -9.96 |
| 2024-12-31 | 8.06 | $-0.88 | -9.21 |
| 2024-09-30 | 8.16 | $-0.66 | -12.40 |
| 2024-06-30 | 6.97 | $-0.62 | -11.27 |
| 2024-03-31 | 10.61 | $-0.47 | -22.36 |
| 2023-12-31 | 8.02 | $-0.22 | -35.72 |
| 2023-09-30 | 8.22 | $-0.64 | -12.77 |
| 2023-06-30 | 8.00 | $0.74 | 10.75 |
| 2023-03-31 | 8.10 | $0.40 | 20.31 |
| 2022-12-31 | 6.28 | $0.72 | 8.74 |
| 2022-09-30 | 6.89 | $1.20 | 5.76 |
| 2022-06-30 | 8.36 | $0.70 | 11.95 |
| 2022-03-31 | 22.85 | $-0.39 | -58.56 |
| 2021-12-31 | 27.61 | $-0.09 | -291.86 |
| 2021-09-30 | 27.85 | $-0.38 | -74.11 |
| 2021-06-30 | 29.32 | $-1.70 | -17.21 |
| 2021-03-31 | 31.74 | $-0.35 | -91.65 |
| 2020-12-31 | 20.80 | $1.70 | 12.22 |
| 2020-09-30 | 15.54 | $1.84 | 8.42 |
| 2020-06-30 | 18.29 | $1.54 | 11.89 |
| 2020-03-31 | 15.50 | $2.23 | 6.96 |
| 2019-12-31 | 29.92 | $3.22 | 9.29 |
| 2019-09-30 | 21.85 | $7.26 | 3.01 |
| 2019-06-30 | 25.22 | $7.63 | 3.30 |
| 2019-03-31 | 24.70 | $7.90 | 3.13 |
| 2018-12-31 | 18.47 | $8.05 | 2.30 |
| 2018-09-30 | 25.67 | $9.26 | 2.77 |
| 2018-06-30 | 23.24 | $10.18 | 2.28 |
| 2018-03-31 | 15.92 | $12.95 | 1.23 |
| 2017-12-31 | 20.78 | $17.05 | 1.22 |
| 2017-09-30 | 14.33 | $15.55 | 0.92 |
| 2017-06-30 | 17.30 | $11.56 | 1.50 |
| 2017-03-31 | 11.03 | $11.48 | 0.96 |
| 2016-12-31 | 14.52 | $9.37 | 1.55 |
| 2016-09-30 | 24.55 | $12.29 | 2.00 |
| 2016-06-30 | 20.14 | $15.75 | 1.28 |
| 2016-03-31 | 26.30 | $16.84 | 1.56 |
| 2015-12-31 | 101.65 | $17.58 | 5.78 |
| 2015-09-30 | 178.38 | $19.33 | 9.23 |
| 2015-06-30 | 222.15 | $19.61 | 11.33 |
| 2015-03-31 | 198.62 | $19.66 | 10.10 |
| 2014-12-31 | 143.11 | $16.15 | 8.86 |
| 2014-09-30 | 131.20 | $15.67 | 8.37 |
| 2014-06-30 | 126.12 | $16.08 | 7.84 |
| 2014-03-31 | 131.83 | $15.60 | 8.45 |
| 2013-12-31 | 117.40 | $15.71 | 7.47 |
| 2013-09-30 | 104.33 | $15.21 | 6.86 |
| 2013-06-30 | 86.08 | $17.15 | 5.02 |
| 2013-03-31 | 75.02 | $11.81 | 6.35 |
| 2012-12-31 | 59.77 | $12.23 | 4.89 |
| 2012-09-30 | 55.27 | $12.50 | 4.42 |
| 2012-06-30 | 44.79 | $12.23 | 3.66 |
| 2012-03-31 | 53.69 | $13.37 | 4.02 |
| 2011-12-31 | 46.69 | $12.83 | 3.64 |
| 2011-09-30 | 37.12 | $13.09 | 2.84 |
| 2011-06-30 | 51.96 | $15.54 | 3.34 |
| 2011-03-31 | 49.81 | $15.82 | 3.15 |
| 2010-12-31 | 28.29 | $16.24 | 1.74 |
| 2010-09-30 | 24.08 | $18.13 | 1.33 |
| 2010-06-30 | 18.42 | $8.58 | 2.15 |
| 2010-03-31 | 15.96 | $8.48 | 1.88 |
| 2009-12-31 | 13.20 | $8.56 | 1.54 |
| 2009-09-30 | 14.50 | 0.00 | |
| 2009-06-30 | 12.55 | 0.00 | |
| 2009-03-31 | 10.14 | 0.00 | |
| 2008-12-31 | 8.45 | $7.59 | 1.11 |
| 2008-09-30 | 8.38 | 0.00 | |
| 2008-06-30 | 7.98 | 0.00 | |
| 2008-03-31 | 8.55 | 0.00 | |
| 2007-12-31 | 10.46 | 0.00 | |
| 2007-09-30 | 13.21 | 0.00 | |
| 2007-06-30 | 18.89 | 0.00 | |
| 2007-03-31 | 16.01 | 0.00 | |
| 2006-12-31 | 14.88 | 0.00 | |
| 2006-09-30 | 10.64 | 0.00 | |
| 2006-06-30 | 16.22 | 0.00 | |
| 2006-03-31 | 16.70 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.129B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |